Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 12;8(11):1950.
doi: 10.3390/jcm8111950.

Clinical Factors Associated with a Shorter or Longer Course of Antibiotic Treatment in Patients with Exacerbations of Bronchiectasis: A Prospective Cohort Study

Affiliations

Clinical Factors Associated with a Shorter or Longer Course of Antibiotic Treatment in Patients with Exacerbations of Bronchiectasis: A Prospective Cohort Study

Giulia Scioscia et al. J Clin Med. .

Abstract

Background: Bronchiectasis exacerbations are often treated with prolonged antibiotic use, even though there is limited evidence for this approach. We therefore aimed to investigate the baseline clinical and microbiological findings associated with long courses of antibiotic treatment in exacerbated bronchiectasis patients.

Methods: This was a bi-centric prospective observational study of bronchiectasis exacerbated adults. We compared groups receiving short (≤14 days) and long (15-21 days) courses of antibiotic treatment.

Results: We enrolled 191 patients (mean age 72 (63, 79) years; 108 (56.5%) females), of whom 132 (69%) and 59 (31%) received short and long courses of antibiotics, respectively. Multivariable logistic regression of the baseline variables showed that long-term oxygen therapy (LTOT), moderate-severe exacerbations, and microbiological isolation of Pseudomonas aeruginosa were associated with long courses of antibiotic therapy. When we excluded patients with a diagnosis of community-acquired pneumonia (n = 49), in the model we found that an etiology of P. aeruginosa remained as factor associated with longer antibiotic treatment, with a moderate and a severe FACED score and the presence of arrhythmia as comorbidity at baseline.

Conclusions: Decisions about the duration of antibiotic therapy should be guided by clinical and microbiological assessments of patients with infective exacerbations.

Keywords: antibiotic course; bronchiectasis; exacerbations; severity.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Chart for study enrollment.
Figure 2
Figure 2
Area under the receiver-operator characteristic curve for the multivariable model.

References

    1. Watt A.P., Brown V., Courtney J., Kelly M., Garske L., Elborn J.S., Ennis M. Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Thorax. 2004;59:231–236. doi: 10.1136/thx.2003.008037. - DOI - PMC - PubMed
    1. Bell S.C., Elborn J.S., Byrnes C.A. Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention. Respirology. 2018;23:1006–1022. doi: 10.1111/resp.13398. - DOI - PubMed
    1. Chalmers J.D., Goeminne P., Aliberti S., McDonnell M.J., Lonni S., Davidson J., Poppelwell L., Salih W., Pesci A., Dupont L.J., et al. The bronchiectasis severity index. An international derivation and validation study. Am. J. Respir. Crit. Care Med. 2014;189:576–585. doi: 10.1164/rccm.201309-1575OC. - DOI - PMC - PubMed
    1. Hill A.T., Haworth C.S., Aliberti S., Barker A., Blasi F., Boersma W., Chalmers J.D., De Soyza A., Dimakou K., Elborn J.S., et al. Pulmonary exacerbation in adults with bronchiectasis: A consensus definition for clinical research. Eur. Respir. J. 2017;49:1700051. doi: 10.1183/13993003.00051-2017. - DOI - PubMed
    1. Martínez-García M.Á., Máiz L., Olveira C., Girón R.M., de la Rosa D., Blanco M., Cantón R., Vendrell M., Polverino E., de Gracia J., et al. Normativa sobre la valoración y eldiagnóstico de lasbronquiectasias en el adulto. Arch. Bronconeumol. 2018;54:79–87. - PubMed